ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1304

Increased Risk of Vertebral Fracture Among Patients with Psoriatic Arthritis: A Systematic Review and Meta-analysis

Patompong Ungprasert1, Nipith Charoenngam2, Ben Ponvilawan3, Jerapas Thongpiya4 and Pitchaporn Yingchoncharoen3, 1Cleveland Clinic, Cleveland Heights, OH, 2Mount Auburn Hospital, Boston, MA, 3Mahidol University, Bangkok, Thailand, 4Mahdiol University, Bangkok, Thailand

Meeting: ACR Convergence 2021

Keywords: Clinical Osteoporosis, Epidemiology, Fracture, meta-analysis, Psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes III: Comorbidities, Extra-muskuloskeletal Manifestations, & Related Conditions (1304–1328)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Increased risk of vertebral fracture (VF) has been documented in several autoimmune diseases as a result of excessive inflammatory burden and use of corticosteroids. The risk is well-established in several autoimmune diseases with high inflammatory burden such as rheumatoid arthritis and systemic lupus erythematosus. However, the risk among patients with autoimmune diseases of less inflammatory burden, including psoriatic arthritis (PsA), is unclear.

Methods: Potentially eligible studies were identified from MEDLINE and EMBASE database from inception to December 2020 using search strategy that comprised of terms for “Psoriatic Arthritis” and “Vertebral Fracture”. Eligible study must be cohort study that consists of one cohort of patients with PsA and another cohort of comparators without PsA. Then, the study must investigate for the prevalence of VF in both groups. Odds ratio (OR) with 95% confidence intervals (95% CIs) comparing prevalent VF between the groups or sufficient raw data to calculate this OR must be provided. Point estimates with standard errors were retrieved from each study and were combined together using the generic inverse variance method. Funnel plot was used to assess for the presence of publication bias.

Results: A total of 26,090 articles were identified. After two rounds of independent review by three investigators, five cohort studies met the eligibility criteria and were included into the meta-analysis. PsA is significantly associated with VF with the pooled odds ratio of 2.09 (95% CI, 1.11 – 3.96; I2 70%) (Figure 1). The funnel plot was fairly symmetric and was not suggestive of publication bias.

Conclusion: This systematic review and meta-analysis found a significantly increased risk of prevalent VF among patients with PsA.

Figure 1: Forest plot of this meta-analysis


Disclosures: P. Ungprasert, None; N. Charoenngam, None; B. Ponvilawan, None; J. Thongpiya, None; P. Yingchoncharoen, None.

To cite this abstract in AMA style:

Ungprasert P, Charoenngam N, Ponvilawan B, Thongpiya J, Yingchoncharoen P. Increased Risk of Vertebral Fracture Among Patients with Psoriatic Arthritis: A Systematic Review and Meta-analysis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/increased-risk-of-vertebral-fracture-among-patients-with-psoriatic-arthritis-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-risk-of-vertebral-fracture-among-patients-with-psoriatic-arthritis-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology